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to the pharmaceutical industry by the NICE initiative.
Although it remains a fairly recent innovation, it would
appear to be timely to undertake an initial assessment of
its implications, both for the pharmaceutical industry and
for national health systems. CONCLUSIONS: The nature
and extent of the learning process through which NICE
has progressed will be explored, together with the current
state of the art with regard to NICE evaluation. In addi-
tion, the potential beneﬁts that arise to health services
from a NICE-style appraisal process will be presented.
Methods by which the clinical and economic evaluations
can be integrated will be presented.
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OBJECTIVES: To select medical technologies that should
be provided to the general public under the National
Health Law. The rapid development of new technologies
and the limited budget of the health care system make the
selection process difﬁcult. The research focused on the
Israeli National Health Care System that faces budgetary
constraint. Once a year a ﬁxed budget has to be allocated
among a set of candidate technologies. The constraint
imposed by the ﬁxed budget must be taken into account
in the decision-making process. METHODS: We devel-
oped a Group Decision Support System based on a 
three-dimensional model: 1) Beneﬁt (measured by the
effectiveness of each technology); 2) Risk (measured by
EBM); and 3) Cost: Based on the Analytical Hierarchy
Process (AHP) methodology, a set of criteria was devel-
oped by a group of medical experts, economists, patient
representatives, sociologists, law experts and ethical
experts. EBM was used to assess the Risk (knowledge
gap) associated with each alternative. While Cost was
estimated by explicit market price of the technology in
consideration. RESULTS: A set of candidate medical
technologies evaluated by the proposed methodology
revealed a clear Pareto distribution. The proposed
methodology helped the decision-makers focus on the
most promising technologies out of a total 193 technolo-
gies proposed. CONCLUSIONS: The proposed method-
ology helped decision makers by focusing their attention
on the most promising medical technologies based on pre-
deﬁned objective set of criteria. The decision process is
more effective and it achieves higher efﬁciency by using
the Group Decision Support System (GDSS).
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The accuracy and reliability of genetic tests has been
rapidly improving, while the cost of such tests is becom-
ing more affordable. The implications of this are poten-
tially drastic: individuals will have access to information
about their genetic predispositions, allowing them to alter
their decisions accordingly. One consideration in this is
the demand for life insurance: an individual at genetic risk
may be inclined to purchase more life insurance in order
to protect her family’s future; however, insurance com-
panies may also try to exclude “bad genetic risks”, assum-
ing they have access to that information. Both actions
lead to adverse selection and inefﬁciency problems in the
insurance market. This paper focuses on the implica-
tions of genetic testing for breast cancer genes (BRCA1
and BRCA2) on life insurance markets. Mutations on
BRCA1/2 genes are not a deﬁnite predictor of breast
cancer: there is roughly an 85% lifetime probability that
a carrier will develop the disease, moreover, individuals
can use prophylaxis and thereby considerably lower their
risk of developing breast cancer. Hence, the interpretation
of a positive test result is complicated, both for the indi-
vidual and for the insurance company. OBJECTIVE: This
paper looks at several scenarios (including different 
age and risk groups and income levels) to determine the
impact on the demand for life insurance by women at
genetic risk for breast cancer. METHOD: The methodol-
ogy used is a microeconomic framework where individ-
uals maximise their expected utility as a function of
insurance purchases, and the insurance company may or
may not know the results of the genetic test. RESULTS:
The results show that women with higher incomes and
higher levels of risk aversion are more likely to purchase
life insurance. CONCLUSIONS: However, women that
are less risk averse and have lower incomes tend to under-
insure themselves, underscoring the need to ensure an
adequate perception of own-risk.
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OBJECTIVE: As part of an “outcomes program” on
smoking cessation, we thought it relevant to evaluate in
smokers under 25 years of age the obstacles to cessation,
the level of dependency, the knowledge of tobacco depen-
dency and the propensity to pay for cessation treatment.
METHOD: For this pilot phase, an anonymous ques-
tionnaire was distributed in the “Etudiant” supplement
of a French regional weekly newspaper. RESULTS:
Obstacle to cessation: lack of willpower (51%), enjoy-
ment of smoking (32%), force of habit (46%) The level
of dependency on tobacco was evaluated using the Fager-
ström test: 48% had low dependency, 48% moderate
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dependency and 2% high dependency. In general, our
sample population had a good general knowledge and
understanding of tobacco use (number of premature
deaths per year, percentage of smokers in France, cost of
tobacco for health insurance). Average daily tobacco
expenses were €2.3 (roughly corresponding to an aver-
age consumption of 10 cigarettes/day), and the subjects
declared themselves ready to pay around €83 to stop
smoking (€157 in older adults). This ﬁgure is relatively
low and is explained without doubt by an underestima-
tion of the potential risks of tobacco dependency. CON-
CLUSION: Young people are a population whose
dependency level is mainly low or moderate, a fact that
enables—with appropriate but generalised mobilization
(doctor, educator, pharmacist, family)—a smoking cessa-
tion attempt to succeed.
HEALTH CARE POLICY—Patient Reported
Outcomes Studies
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A Health care program involves many dimensions, 
and its appraisal requires multicriteria decision analysis. 
This applies to new organisations for Health care deliv-
ery set up in France as “co-ordinated networks”. Their
objectives are to combine health and social care inter-
ventions in a structured framework, in hospital and out-
patient settings in order to optimise Health care services.
The Health care network “Quietude” was set in Paris for
out-patient palliative care: to permit termination phase
patients to die at home, to optimise symptoms care and
hospitalisation, and to keep patients’ families informed
about care, medications, and administrative procedures.
OBJECTIVE: To evaluate several dimensions of the
“Quietude” network, medical care, organisation, pa-
tients, professionals and families satisfaction, and eco-
nomic impact. METHODS: Qualitative and quantitative
studies were based on interviews, questionnaires, Delphi
panels, and data currently collected through the network
ITS (N patient’s = 435). RESULTS: Mean LOS is 40 days,
and mean Health care cost per day is €190. Ambulatory
care represents 80%, medication 15.5% and coordina-
tion 4.5%. Quality of care is considered as satisfactory
by 94% of families and professionals. Over 95% of the
professionals think pain and symptoms treatments are
completely managed compared to 80% of families. Other
discrepancies in perception are observed in emergency
management, (92% vs. 68%), hospitalisation planning
(92% vs. 75%), continuity of care (95% vs. 80%), and
administrative information access (79% vs. 70%). A total
of 75% of professionals think patients’ wishes for the
location of their death were respected. Needs for improv-
ing population targeting and ITS were identiﬁed. CON-
CLUSIONS: Most objectives set by “Quietude” with
regard to the Health care resources commonly employed
during the last months of life were achieved to the beneﬁt
of patients, professionals, and families at a very low 
coordination cost. Multicriteria analysis is particularly
adapted to an appraisal of this type of innovative Health
care provision.
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OBJECTIVES: Understanding how to develop marketing
messages for Health care consumers presents a constant
challenge for pharmaceutical companies. By using patient
reported outcomes data, the objective of this study was
to segment the various types of Health care consumers
and uncover each group’s receptiveness to pharmaceuti-
cal advertising. METHODS: An annual, self-reported
study of U.S. consumer attitudes and behaviors was
ﬁelded in June 2002 and included 30,213 adult respon-
dents. We stratiﬁed and weighted the sample by key
demographics. We then conducted a cluster analysis on
20 Health care opinions designed to evaluate health-
related compliance and proactivity. RESULTS: Health
care consumers segmented into ﬁve clusters based on a
variety of patient reported outcomes: attitudes, opinions,
demographics, and Health care resource use. Brand
Believers (22% or 44.5 Million) endorse the brand con-
tract and are most receptive to marketing efforts. Rock-
wellians (24% or 49 Million) are driven by trust and
value the relationship with their physician. What-Me
Worry? (18% or 37.2 Million) are quite conﬁdent in their
ability to obtain the appropriate Health care. Young and
Angry (18% or 36.5 Million) have been let down in
someway by the Health care system. Novice Nellies (18%
or 36.8 Million) require training to interpret Health care
messages. CONCLUSIONS: Patient reported outcomes
data can assist pharmaceutical companies proﬁle and
understand each consumer segment. This analysis reveals
that two speciﬁc segments (Brand Believers and Rock-
wellian) or 93.5 Million U.S. consumers are more recep-
tive to pharmaceutical marketing efforts than the other
three segments. Further analysis of these two consumer
segments within a speciﬁc therapeutic condition would
yield additional insight into the attitudes and behaviors
of each group.
